Market Overview - The stock market is experiencing volatility, with the S&P 500 index falling nearly 20% from February highs but recovering fully by May 22 [1] - Investors are concerned about high tariffs, a proposed major tax bill, and the potential for recession or rising inflation [1] Amgen - Amgen is a pharmaceutical company known for its diverse range of drugs, including Enbrel, Prolia, XGEVA, Otezla, and Repatha [3] - The company is developing a weight-loss drug, MariTide, and has initiated two phase 3 trials [4] - In Q1, Amgen reported adjusted earnings of $4.90 per share, surpassing Wall Street estimates of $4.26, with revenue growth of 9% year over year [6] - Amgen has consistently paid dividends since 2011, increasing them for 14 consecutive years, with a current dividend yield of approximately 3.5% [7] - Management expects free cash flow to rebound to $7.4 billion in 2023, covering the expected $5.2 billion in dividend payments [7] Sirius XM - Sirius XM is a leading digital audio company in the U.S., operating Sirius satellite radio and Pandora, reaching 160 million listeners monthly [8] - The company has faced significant challenges, with stock down about 57% over the last five years due to rising competition and declining subscribers [8] - Management is investing in technology, expanding its podcast network, and streamlining subscription offerings, aiming for a 25% increase in subscribers to 50 million and a 50% increase in free cash flow to $1.8 billion [9] - In Q1, Sirius XM's revenue fell 4.3% year over year, and total U.S. subscribers declined by 2% [10] - The company offers a 4.9% dividend yield, having regularly paid and increased its annual dividend since 2017, with a trailing free cash flow yield close to 10% [11]

Core Points - Plus Therapeutics, Inc. received a delinquency notification from Nasdaq due to delayed filing of its Quarterly Report for the period ended March 31, 2025 [1] - The company is required to submit a compliance plan by July 21, 2025, and if accepted, may receive an extension until November 17, 2025 [2] - Plus Therapeutics is a clinical-stage pharmaceutical company focused on developing targeted radiotherapeutics for challenging cancers of the central nervous system [3] Company Overview - Plus Therapeutics is headquartered in Houston, Texas, and is developing a pipeline of product candidates aimed at improving clinical outcomes for difficult-to-treat cancers [3] - The company combines image-guided local beta radiation with targeted drug delivery approaches, with lead programs in leptomeningeal metastases and recurrent glioblastoma [3] - Plus Therapeutics has established a supply chain through strategic partnerships to support the development, manufacturing, and potential commercialization of its products [3]

Delisting of Securities of Bruush Oral Care Inc., IX Acquisition Corp., BAIYU Holdings, Inc., DUET Acquisition Corp., ENGlobal Corporation, Perception Capital Corp. III, Biora Therapeutics, Inc., Akoustis Technologies, Inc., iLearningEngines, Inc., Welsbach Technology Metals Acquisition Corp., Cartica Acquisition Corp, CSLM Acquisition Corp., Broad Capital Acquisition Corp, Technology & Telecommunication Acquisition Corporation, Western Acquisition Ventures Corp., Papaya Growth Opportunity Corp. I, Canoo I ...

Market Overview - U.S. stocks traded lower, with the Nasdaq Composite falling more than 1% on Friday, Dow down 0.70% to 41,566.04, NASDAQ down 1.12% to 18,713.37, and S&P 500 down 0.87% to 5,791.25 [1] - Real estate shares fell by 0.1%, while information technology stocks dipped by 1.4% [1] Company Performance - Workday, Inc. (WDAY) shares dipped more than 11% after reporting quarterly earnings of $2.23 per share, beating the analyst consensus estimate of $2.01 by 10.95%. Quarterly revenue was $2.24 billion, exceeding the Street estimate of $2.22 billion. However, Workday projected second-quarter revenue of $2.16 billion, below the $2.34 billion analyst estimate [2] Commodity Market - Oil traded up 0.4% to $61.42, gold up 1.5% at $3,344.90, silver up 0.1% to $33.250, and copper rose 1% to $4.7245 [4] European Market - European shares were lower, with the eurozone's STOXX 600 falling 1.1%, Spain's IBEX 35 Index down 1.5%, London's FTSE 100 down 0.85%, Germany's DAX 40 declining 1.6%, and France's CAC 40 falling 1.9% [5] Asian Market - Asian markets closed mostly higher, with Japan's Nikkei gaining 0.47%, Hong Kong's Hang Seng Index rising 0.24%, China's Shanghai Composite Index falling 0.94%, and India's BSE Sensex gaining 0.95% [6] Stock Movements - Imunon, Inc. (IMNN) shares surged 155% to $1.07 after announcing new data from its Phase 2 OVATION 2 Study of IMNN-001. Powell Max Limited (PMAX) shares rose 84% to $0.5956, and BloomZ Inc. (BLMZ) shares gained 52% to $0.2033 following a business alliance announcement [8] - Conversely, Golden Heaven Group Holdings Ltd. (GDHG) shares dropped 51% to $2.26, and Bicara Therapeutics Inc. (BCAX) shares fell 42% to $9.06 after mixed results from a phase 1/1b trial [8] Housing Market - U.S. sales of new single-family homes climbed by 10.9% from the previous month to an annualized rate of 743,000 units [9]

Market Reaction - Major US stock indexes experienced significant declines, with the Dow down 380 points (0.9%), S&P 500 down 1.1%, and Nasdaq down 1.4% in early trading [1] - US stock futures extended losses following President Trump's tariff threats, with Nasdaq futures down 1.9%, Dow futures down 1.5%, and S&P 500 futures down 1.6% [4] Trade Tensions - President Trump proposed substantial tariffs on EU goods and suggested a 25% import tax on Apple if iPhones are not manufactured in the US [2][6] - Analysts expressed concerns that the current rhetoric represents a destabilizing threat, increasing the risk of recession and long-term damage to US credibility [2] Bond Market and Safe Haven Assets - Bond yields dropped sharply, with the 10-year Treasury yield falling 12 basis points to 4.10%, indicating a flight to safety among investors [3] - Gold prices spiked, reflecting market apprehension, while the dollar gained strength [3] Economic Indicators - Traders are monitoring upcoming economic data, including April's new home sales, as they prepare for a bond market close ahead of the Memorial Day weekend [3] Political Developments - The House of Representatives passed President Trump's tax and spending package by a narrow margin, raising concerns about its impact on bond markets and US debt levels [10]

Core Viewpoint - China Liberal Education Holdings Limited has received a notice from Nasdaq regarding its delinquency in filing the Annual Report on Form 20-F for the fiscal year ended December 31, 2024, which may lead to delisting from Nasdaq [1] Group 1: Company Status and Actions - The Company has scheduled a hearing before Nasdaq's Hearings Panel on June 10, 2025, and has until May 28, 2025, to request a stay of the suspension [2] - The Company is actively working to finalize and file its delayed Form 20-F, which has been substantially drafted prior to the original deadline [3] - The operations of the Company remain unaffected by the receipt of the Staff Determination Notices [3] Group 2: Compliance and Background - The announcement is made in compliance with Nasdaq Listing Rule 5810(b), which mandates prompt disclosure of deficiency notifications [4] - China Liberal provides technological consulting services for smart campus solutions and other educational services, aimed at enhancing the management and operational environment of universities [5]

Market Overview - U.S. stocks traded mostly higher, with the Nasdaq Composite gaining over 100 points on Thursday [1] - The Dow rose 0.01% to 41,866.30, the NASDAQ increased by 0.74% to 19,011.97, and the S&P 500 gained 0.20% to 5,856.20 [1] Sector Performance - Communication services shares increased by 1.7% on Thursday [1] - Utilities stocks experienced a decline of 1.8% [1] Company Earnings - BJ's Wholesale Club Holdings, Inc. reported adjusted earnings per share of $1.14, exceeding the analyst consensus estimate of 92 cents [2] - Quarterly revenues were $5.15 billion, a 4.7% year-over-year increase, but fell short of the expected $5.20 billion [2] - The company reaffirmed its full-year 2025 adjusted earnings guidance of $4.10 to $4.30 per share, compared to the $4.24 estimate [2] Stock Movements - Vigil Neuroscience, Inc. shares surged 243% to $7.91 following the announcement of its acquisition by Sanofi for approximately $600 million [8] - Navitas Semiconductor Corporation shares rose 128% to $4.3335 after being selected by NVIDIA for collaboration [8] - Advance Auto Parts, Inc. shares increased by 44% to $45.14 due to better-than-expected first-quarter results [8] - CEL-SCI Corporation shares dropped 46% to $2.4309 after announcing a $5 million public offering [8] - Sunrun Inc. shares fell 40% to $6.44 after a downgrade from BMO Capital [8] - Enphase Energy, Inc. shares decreased by 16% to $39.85 [8] Economic Indicators - U.S. existing home sales fell 0.5% month-over-month to an annual rate of 4.00 million, the lowest level in six months [10] - The S&P Global services PMI rose to 52.3 in May from 50.8 in April [10] - The S&P Global manufacturing PMI increased to 52.3 in May from 50.2 in April [10] - The Chicago Fed National Activity Index decreased to -0.25 in April from +0.03 in March [10] - U.S. initial jobless claims fell by 2,000 to 227,000 in the week ending May 17, compared to market estimates of 230,000 [10]

Core Insights - The article highlights the 28th annual list of the world's most influential businesswomen, emphasizing the increasing competition as more women lead significant companies. The ranking is data-driven, utilizing a complex scoring system that considers various dimensions beyond just company size and performance [1][2]. Group 1: Rankings and Notable Leaders - The top three positions are held by Mary Barra (CEO of General Motors), Julie Sweet (CEO of Accenture), and Jane Fraser (CEO of Citigroup) [1][2]. - The list includes leaders from various global companies, with notable mentions from Walmart and Netflix [1]. Group 2: Geographic Representation - Over half of the women on the list work in the United States, with significant representation from China (10), France (7), the UK (7), and Brazil (3) [2]. - The Chinese representatives include notable figures such as Meng Wanzhou (Huawei), Joey Wat (Yum China), and others from leading companies [2]. Group 3: Emerging Leaders - Among the 16 new entrants, several have returned to the list after years, including Michelle Gass (CEO of Levi's) and Claudine Adamo (Chief Procurement Officer at Costco) [2]. - The list reflects a mix of seasoned executives and rising stars, indicating a dynamic shift in leadership [2]. Group 4: Business Performance and Challenges - General Motors, under Mary Barra, achieved record revenue in 2024, with a 9% year-over-year increase, and doubled its market share in electric vehicles [6]. - Citigroup, led by Jane Fraser, reported a net profit increase from $9.2 billion in 2023 to $12.7 billion in 2024, prompting a $20 billion stock buyback plan [10]. - Accenture, under Julie Sweet, demonstrated agility by hosting webinars for 900 clients in response to new tariffs, showcasing the ability to adapt quickly to market changes [7]. Group 5: Industry Trends and Innovations - The article notes a shift in evaluating business influence, with a diminishing absolute reliance on company size, as seen with Mira Murati of Thinking Machines Lab, who leads a seed-stage company [3]. - The focus on technology and innovation is evident, with leaders like Safra Catz of Oracle and Lisa Su of AMD navigating challenges in the tech sector while pushing for advancements in AI [11][42].

Core Viewpoint - Conduit Pharmaceuticals Inc. has received approval from Nasdaq to transfer its common stock listing to The Nasdaq Capital Market, effective May 23, 2025, following compliance with necessary requirements [1]. Company Overview - Conduit Pharmaceuticals is a clinical stage life science company that employs an efficient model for compound development, focusing on acquiring and funding Phase 2-ready assets [2]. - The company utilizes a platform-driven approach powered by artificial intelligence (AI) and cybernetics, aiming for exits through third-party license deals after successful clinical trials [2]. - The leadership team includes experienced executives such as Dr. Andrew Regan and Dr. Freda Lewis-Hall, marking a shift from traditional pharma/biotech business models [2].

Core Viewpoint - Nasdaq and the Philippine Stock Exchange (PSE) are enhancing their technology partnership by upgrading PSE's trading infrastructure to Nasdaq's advanced platform, Nasdaq Eqlipse Trading, which aims to improve liquidity and resilience in the Philippine marketplace [1][5]. Group 1: Technology Partnership - The upgrade to Nasdaq Eqlipse Trading represents a significant investment by Nasdaq to modernize and strengthen its platform capabilities, allowing for enhanced functionality such as pre-trade risk management and advanced options pricing [2][4]. - PSE's decision to renew its partnership with Nasdaq is driven by the need for a reliable trading system that meets current and future requirements, emphasizing the importance of technology in PSE's strategic agenda [3][5]. Group 2: Market Impact - The Nasdaq Eqlipse platform is part of a broader initiative to develop a fully interoperable suite of solutions across trading, clearing, and data intelligence, marking a major milestone in Nasdaq's investment cycle [4]. - Nasdaq's technology is utilized by 97% of globally significant banks and half of the world's top 25 stock exchanges, indicating its critical role in enhancing market infrastructure and operational efficiency [6]. Group 3: Economic Context - The partnership aligns with the rapid economic growth of the Philippines, positioning Nasdaq to support local and global banks in navigating challenges and innovating in a digital and AI-driven environment [6]. - Nasdaq's presence in the Philippines is part of its strategy to drive modernization in the financial services industry, contributing to regulatory compliance and simplifying capital market operations [5][6].